Macquarie Group’s Natus Medical Inc NTUS Stock Holding History

Macquarie Group’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-425	Closed	-$14K	–	2575
2022 Q2	$14K	Hold	425	–	–	﹤0.01%	2398
2022 Q1	$11	Hold	425	–	–	﹤0.01%	2514
2021 Q4	$10K	Hold	425	–	–	﹤0.01%	2520
2021 Q3	$11K	Hold	425	–	–	﹤0.01%	2537
2021 Q2	$11K	Hold	425	–	–	﹤0.01%	2465
2021 Q1	$11K	Sell	425 -201	-32%	-$5.15K	﹤0.01%	2386
2020 Q4	$13K	Hold	626	–	–	﹤0.01%	2282
2020 Q3	$11K	Hold	626	–	–	﹤0.01%	2276
2020 Q2	$14K	Buy	+626	New	+$14.3K	﹤0.01%	2248

Other funds holding NTUS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group's NTUS Position: Q3 2022 in Review

Macquarie Group sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 425 shares — an estimated $14K sold.

Macquarie Group first reported a position in NTUS in Q2 2020 and held it in 9 quarters. The position peaked at $14K in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

Macquarie Group reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
Macquarie Group sold 425 Natus Medical Inc shares in Q3 2022, an estimated $14K.
Macquarie Group first reported a position in Natus Medical Inc in Q2 2020 and held it in 9 quarters.
Macquarie Group's Natus Medical Inc position peaked at $14K in Q2 2022.
1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.